Optimisation of the quantification of glutamine synthetase and myelin basic protein in cerebrospinal fluid by a combined acidification and neutralisation protocol-Reference-Cited by-同舟云学术

Optimisation of the quantification of glutamine synthetase and myelin basic protein in cerebrospinal fluid by a combined acidification and neutralisation protocol

Published:2012-07 Issue:1-2 Volume:381 Page:1-8
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Herbert Megan K.,Kuiperij H. Bea,Verbeek Marcel M.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference38 articles.

1. Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease;Abdo;Mov. Disord.,2004

2. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis;Belogurov;J. Immunol.,2008

3. Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides;Bibl;Electrophoresis,2004

4. Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid;Bjerke;Int. J. Alzheimer's Dis.,2010

5. Heat-induced antigen retrieval: what are we retrieving?;Boenisch;J. Histochem. Cytochem.,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD;Journal of Neurology, Neurosurgery & Psychiatry;2020-03-26

2. In Vivo Determination of Glutamate Uptake by Brain Microdialysis;Neuromethods;2017-09-22

3. Total glutamine synthetase levels in cerebrospinal fluid of Alzheimer's disease patients are unchanged;Neurobiology of Aging;2015-03

4. Structural biomarkers in the cerebrospinal fluid within 24 h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects;Spinal Cord;2014-04-08